You are viewing an incomplete version of our website. Please click to reload the website as full version.

serine/threonine Kinase 17b (STK17B) (C-Term) Peptide

Details for Product No. ABIN1382031, Supplier: Log in to see
Protein Name
  • 3110009A03Rik
  • AI120141
  • Drak2
  • DRAK2
  • STK17B
  • zgc:65989
Protein Region
C-Term
Origin
Human
4
2
2
2
Application
Blocking Peptide (BP)
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Blocked Antibody anti-serine/threonine Kinase 17b (STK17B) (C-Term) antibody (ABIN1030368)
Characteristics 15 amino acids near the carboxy terminus of human DRAK2.
Human
Research Area Signaling, Apoptosis/Necrosis
Application Notes DRAK2 peptide is used for blocking the activity of DRAK2.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Sanjo, Kawai, Akira: "DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis." in: The Journal of biological chemistry, Vol. 273, Issue 44, pp. 29066-71, 1998